Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

Completed · Phase 2

Conditions studied: Hypogonadism

In brief

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.

Key facts

Study ID

NCT00372008

Run by

Acrux DDS Pty Ltd

People needed

40

Starts

2006-10-01

Expected to finish

2007-04-01

Last updated by the study team

2008-06-20

Who can join

Age: 18 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Hypogonadal males between 18-70 years old with qualifying general medical health

You may not qualify if…

• Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy

Where it is running

• Birmingham — Birmingham, Alabama, United States
• Study site — La Mesa, California, United States
• Study site — Torrance, California, United States
• Study site — New Britain, Connecticut, United States
• Study site — Ocala, Florida, United States
• Study site — Shreveport, Louisiana, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.